Universal Health Services (UHS)
(Delayed Data from NYSE)
$185.97 USD
+0.67 (0.36%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $196.06 +10.09 (5.43%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Universal Health Services, Inc. [UHS]
Reports for Purchase
Showing records 441 - 452 ( 452 total )
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
Initiating Coverage with HOLD Rating
Provider: KEYBANC CAPITAL MARKETS
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
UHS to Further Expand its Behavioral Footprint through the Acquisition of Ascend Health Services
Provider: AURIGA USA
Analyst: LOSEV G
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
1Q12: Acute Trends Improve, but Margin Pressure Forces EPS Miss; Robust Growth in Behavioral Continues
Provider: AURIGA USA
Analyst: LOSEV G
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
Flu Activity Down Y/Y; Non-Flu IP Volumes Increase; Las Vegas'' Improving
Provider: AURIGA USA
Analyst: LOSEV G
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
4Q11 In-Line; 2012 Guidance Appears Conservative; Maintain Buy; Raise PT to $51
Provider: AURIGA USA
Analyst: LOSEV G
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
3Q11 Review: Quarter In-Line with Expectations; Continued Solid Behavioral Business Overshadows Softness in Acute
Provider: AURIGA USA
Analyst: LOSEV G
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
MERGERS & ACQUISITIONS
Provider: WALL STREET ACCESS CORP.
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
Provider: Zacks Investment Research
Analyst: KALLOS C
Company: Universal Health Services, Inc.
Industry: Medical - Hospital
Provider: Zacks Investment Research
Analyst: KALLOS C